The novel coronavirus, known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?
Potentially flawed models may result in making inappropriate decisions on Covid-19 patients
How to sleep better during coronavirus lockdown
Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines
Dispatch from a country doctor: Seeing patients differently in the time of coronavirus
Researchers gain new insight into how lipids function within tears
Inside meals on wheels’ struggle to keep older Americans fed during a pandemic
Perimenopause and Diet
Protein Supplements and Neurodegenerative Disorders
Does the Hand You Write with Affect Brain Development?
An Overview of Dopamine Receptor Pharmacology
What is the Skin Microbiome?
Deliver any compound into any adherent cell - easy and precise solution for your drug assay
Using MRI to Diagnose Autism Spectrum Disorder
Using Microparticles to Repair and Detox Cardiac Muscle
How are Probiotic Formulations Validated?
The process of organogenesis is the formation of organs during embryonic development. This article looks at the various organs formed.
Progress towards a cure for HIV has been the holy grail for HIV researchers since bursting into the public consciousness in 1981.
Painsomnia is experienced by anyone with a chronic pain causing them to lose sleep, which in turn lowers their tolerance to pain.
Dr. Andrew Webb
Dr. Andrew Webb describes how his lab uses mass spectrometry-based techniques to understand the role of post-translational modifications in human disease.
Dr Maureen Bunger
Lonza is a large, multinational corporation serving the entire pharmaceutical product development and manufacturing pipeline, from non-clinical research products to final dosage and delivery solutions.
Dr. Dan Lavery
News-Medical speaks to Dr. Dan Lavery about the LouLou Foundation, a non-profit organization dedicated to CDLK5 Deficiency Disorder.
Building a Successful Email Campaign for a Scientific Audience
Using Webinars to Tell Science Stories – PART II
Reaching Scientists Through Newsletters